134 related articles for article (PubMed ID: 34216252)
1. Prevalence and clinical characteristics of prediabetes and diabetes mellitus in young patients with ST-segment elevation myocardial infarction.
Mata Marín LA; Schmucker J; Fach A; Osteresch R; Rühle S; Garstka D; Eitel I; Hambrecht R; Wienbergen H
Clin Res Cardiol; 2021 Oct; 110(10):1647-1658. PubMed ID: 34216252
[TBL] [Abstract][Full Text] [Related]
2. Impact of glycemic control status on patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
Li Y; Li X; Zhang Y; Zhang L; Wu Q; Bai Z; Si J; Zuo X; Shi N; Li J; Chu X
BMC Cardiovasc Disord; 2020 Jan; 20(1):36. PubMed ID: 32000678
[TBL] [Abstract][Full Text] [Related]
3. Angiographic Severity of Coronary Artery Disease in Diabetic and Non-diabetic Acute STEMI Patients in a Tertiary Care Centre of Nepal.
Pathak SR; Gajurel RM; Poudel CM; Shrestha H; Thapa S; Thapa S; Koirala P
Kathmandu Univ Med J (KUMJ); 2021 Oct.-Dec.; 19(76):410-414. PubMed ID: 36259180
[TBL] [Abstract][Full Text] [Related]
4. Missed Opportunities for Screening and Management of Dysglycemia among Patients Presenting with Acute Myocardial Infarction in North India: The Prospective NORIN STEMI Registry.
Ostrominski JW; Vaduganathan M; Girish MP; Gupta P; Hendrickson MJ; Qamar A; Arora S; Pandey A; Bansal A; Batra V; Mahajan B; Mukhopadhyay S; Yusuf J; Tyagi S; Bhatt DL; Gupta MD;
Glob Heart; 2022; 17(1):54. PubMed ID: 36051328
[TBL] [Abstract][Full Text] [Related]
5. General glycosylated hemoglobin goals potentially increase myocardial infarction severity in diabetes patients with comorbidities: Insights from a nationwide multicenter study.
Che Q; Zhang Y; Wang J; Wan Z; Fu X; Chen J; Yan H; Chen Y; Ge J; Chen D; Huo Y
J Diabetes Investig; 2020 Nov; 11(6):1498-1506. PubMed ID: 32383543
[TBL] [Abstract][Full Text] [Related]
6. Two-Year Clinical Outcomes Between Prediabetic and Diabetic Patients With STEMI and Multivessel Disease Who Underwent Successful PCI Using Drug-Eluting Stents.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Angiology; 2021 Jan; 72(1):50-61. PubMed ID: 32806925
[TBL] [Abstract][Full Text] [Related]
7. Utility of Glycated Hemoglobin for Assessment of Glucose Metabolism in Patients With ST-Segment Elevation Myocardial Infarction.
Aggarwal B; Shah GK; Randhawa M; Ellis SG; Lincoff AM; Menon V
Am J Cardiol; 2016 Mar; 117(5):749-53. PubMed ID: 26768673
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and clinical outcomes of undiagnosed diabetes mellitus and prediabetes among patients with high-risk non-ST-segment elevation acute coronary syndrome.
Giraldez RR; Clare RM; Lopes RD; Dalby AJ; Prabhakaran D; Brogan GX; Giugliano RP; James SK; Tanguay JF; Pollack CV; Harrington RA; Braunwald E; Newby LK
Am Heart J; 2013 Jun; 165(6):918-925.e2. PubMed ID: 23708162
[TBL] [Abstract][Full Text] [Related]
9. Impact of glycemic gap on 30-day adverse outcomes in patients with acute ST-segment elevation myocardial infarction.
Wu S; Yang YM; Zhu J; Xu W; Wang LL; Lyu SQ; Wang J; Shao XH; Zhang H
Atherosclerosis; 2022 Nov; 360():34-41. PubMed ID: 36265428
[TBL] [Abstract][Full Text] [Related]
10. The impact of stage of chronic kidney disease on the outcomes of diabetics with acute myocardial infarction treated with percutaneous coronary intervention.
Vichova T; Knot J; Ulman J; Maly M; Motovska Z
Int Urol Nephrol; 2016 Jul; 48(7):1137-43. PubMed ID: 26995007
[TBL] [Abstract][Full Text] [Related]
11. Characteristics, Management, and Outcome of Transient ST-elevation Versus Persistent ST-elevation and Non-ST-elevation Myocardial Infarction.
Blondheim DS; Kleiner-Shochat M; Asif A; Kazatsker M; Frimerman A; Abu-Fanne R; Neiman E; Barel M; Levy Y; Amsalem N; Shotan A; Meisel SR
Am J Cardiol; 2018 Jun; 121(12):1449-1455. PubMed ID: 29699746
[TBL] [Abstract][Full Text] [Related]
12. Impact of initial glycosylated hemoglobin level on cardiovascular outcomes in prediabetic patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Shin D; Ahn J; Cha KS; Park JS; Oh JH; Lee HW; Hong JY; Kim BW; Hong TJ;
Coron Artery Dis; 2016 Jan; 27(1):40-6. PubMed ID: 26398151
[TBL] [Abstract][Full Text] [Related]
13. Prospective study of the impact of diabetes mellitus newly diagnosed by glycated hemoglobin on outcomes in patients undergoing percutaneous coronary intervention.
Tailakh MA; Friger M; Zahger D; Sidi A; Mazor-Dray E; Novack V
Eur J Intern Med; 2017 Jan; 37():69-74. PubMed ID: 27665509
[TBL] [Abstract][Full Text] [Related]
14. Optimal glucose, HbA1c, glucose-HbA1c ratio and stress-hyperglycaemia ratio cut-off values for predicting 1-year mortality in diabetic and non-diabetic acute myocardial infarction patients.
Sia CH; Chan MH; Zheng H; Ko J; Ho AF; Chong J; Foo D; Foo LL; Lim PZ; Liew BW; Chai P; Yeo TC; Tan HC; Chua T; Chan MY; Tan JWC; Bulluck H; Hausenloy DJ
Cardiovasc Diabetol; 2021 Oct; 20(1):211. PubMed ID: 34666746
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of unrecognized diabetes, prediabetes and metabolic syndrome in patients undergoing elective percutaneous coronary intervention.
Balakrishnan R; Berger JS; Tully L; Vani A; Shah B; Burdowski J; Fisher E; Schwartzbard A; Sedlis S; Weintraub H; Underberg JA; Danoff A; Slater JA; Gianos E
Diabetes Metab Res Rev; 2015 Sep; 31(6):603-9. PubMed ID: 25728823
[TBL] [Abstract][Full Text] [Related]
16. The association between glucose-related variables and plaque morphology in patients with ST-segment elevated myocardial infarction.
Liu J; Wang S; Cui C; Cai H; Sun R; Pan W; Fang S; Yu B
Cardiovasc Diabetol; 2020 Jul; 19(1):109. PubMed ID: 32641042
[TBL] [Abstract][Full Text] [Related]
17. Prediabetes versus type 2 diabetes mellitus based on pre-percutaneous coronary intervention thrombolysis in myocardial infarction flow grade in patients with ST-segment elevation myocardial infarction after successful newer-generation drug-eluting stent implantation.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Diab Vasc Dis Res; 2021; 18(1):1479164121991505. PubMed ID: 33535819
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers in acute ST-segment elevation myocardial infarction patients with diabetes mellitus undergoing percutaneous coronary intervention.
Choi SY; Choi BG; Rha SW; Byun JK; Shim MS; Li H; Mashaly A; Choi CU; Park CG; Seo HS; Oh DJ; Jeong MH;
Int J Cardiol; 2017 Dec; 249():48-54. PubMed ID: 28867244
[TBL] [Abstract][Full Text] [Related]
19. Assessment of diabetes and prediabetes prevalence and predictors by HbA1c in a population from sub-Saharan Africa with a high proportion of anemia: a prospective cross-sectional study.
Hodel NC; Hamad A; Reither K; Mwangoka G; Kasella I; Praehauser C; Abdulla S; Hatz CFR; Mayr M
BMJ Open Diabetes Res Care; 2020 May; 8(1):. PubMed ID: 32439737
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Outcomes and Prognosis of Patients With Versus Without Newly Diagnosed Diabetes Mellitus After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (the HORIZONS-AMI Study).
Ertelt K; Brener SJ; Mehran R; Ben-Yehuda O; McAndrew T; Stone GW
Am J Cardiol; 2017 Jun; 119(12):1917-1923. PubMed ID: 28427734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
